FSRC is engaged in Africa, Eastern Europe, South East Asia and CIS with initiatives that highlight the socioeconomic burden inflicted by selected diseases. One of the main areas of focus for FSRC has been hepatitis and working on access related initiatives in the emerging markets. The key goal for all these initiatives is to bridge the gap that exists between what needs to be done and what is actually being done from a health delivery aspect. To achieve this, we work with local stakeholders to develop and implement action plans to help the local policy makers to manage diseases more effectively and improve health access for patients.

  • In Egypt, which has the world’s highest HCV (hepatitis C) prevalence, FSRC recently completed a study to estimate the economic impact of failing to treat hepatitis C at an early stage. This report is currently being disseminated through a variety of formats and communication channels to improve awareness about HCV, potentially resulting in greater focus and better management of the disease

  • We are collaborating with multiple stakeholders to ascertain the burden of hepatitis C in CIS countries. In the region we have been able to bring together stakeholders in the management of hepatitis to take a collective stance on the approach to the battle against hepatitis

  • Through our CA(2)RE framework, FSRC united the disparate English speaking countries of Sub-Saharan Africa under a single umbrella in their fight against HCV. To further the cause, we have partnered with a major African group representing French speaking Africa to expand our reach over the entirety of the continent
We constantly strive towards identifying and recommending the best healthcare practices in those areas where effective and comprehensive healthcare policies are not in place. Through this strategy, we hope to contribute to the larger goal of providing effective health access to everyone.

Our Work